According to the union representing workers at the CAMI EV assembly plant (via The London Free Press), GM is unexpectedly halting production for the month due to a battery shortage.After announcing a CAD 1 billion (roughly $750 million) investment to convert the assembly plant last year, GM said it would begin production of its BrightDrop electric delivery vans in December 2022. Following retooling the plant this past spring and summer, the first 50 BrightDrop EV vans were deployed from the facility in June.The first BrightDrop Zevo 600 rolled off the CAMI production line (Source: GM Canada)Unifor Local 88 chairperson Mike Van Boekel said, high demand and limited production ability is the reason for the shutdown. Although “sales are through the roof” and “things are good,” he explained:They’re out at all GM plants, they need batteries and it stems from a raw material bottleneck.GM is in the process of building more battery capacity, but “it doesn’t happen overnight,” Van Boekel added.According to the report, workers are expected to return to work at the CAMI assembly plant on July 31. Sources close to the facility report GM is building a 400,000 square feet addition to assemble its own batteries to support BrightDrop production.(Source: BrightDrop)The CAMI facility is building electric delivery vans for FedEx, Walmart, Hertz, Verizon, DHL Canada, and more.GM currently has one battery plant building Ultium batteries in Warren, OH, which began production last fall. It has three more planned. Its second is expected to start operations later this year in Spring Hill, TN, while its third in Lansing, MI, is slated to open in 2024
- Forums
- ASX - By Stock
- Media Reports
According to the union representing workers at the CAMI EV...
-
- There are more pages in this discussion • 1,929 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
49.0¢ |
Change
-0.025(4.85%) |
Mkt cap ! $419.8M |
Open | High | Low | Value | Volume |
51.5¢ | 51.5¢ | 49.0¢ | $2.304M | 4.637M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 618511 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.5¢ | 71592 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 618511 | 0.490 |
12 | 445062 | 0.485 |
18 | 382250 | 0.480 |
9 | 453098 | 0.475 |
16 | 318785 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.495 | 71592 | 4 |
0.500 | 75268 | 3 |
0.505 | 120709 | 4 |
0.510 | 74100 | 6 |
0.515 | 128622 | 3 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
49.0¢ |
  |
Change
-0.025 ( 5.77 %) |
|||
Open | High | Low | Volume | ||
51.0¢ | 51.0¢ | 49.0¢ | 1219056 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
SYR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online